John Lund, MD
Cardiovascular Disease · Ogden, UTNPI 1477578557
Payments from drug & device makers
Across 37 payments — averaging $67.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Biosense Webster, Inc.$336
- Medtronic$274
- Boston Scientific$120
- Novartis$51
- Biotronik Inc.$24
- plus $29 from 2 others
What the payments were for
- Food & beverage$874100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 6 | $1,668 |
| Biosense Webster, Inc. | 12 | $336 |
| Medtronic(2 entities) | 10 | $274 |
| Boston Scientific | 3 | $120 |
| Novartis | 3 | $51 |
| Biotronik Inc. | 1 | $24 |
| Bard Peripheral Vascular, Inc. | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
How this compares
$2,501 in reported general payments places this provider in the 50th percentile of 131 cardiovascular disease providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 91 | $105,294 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 49 | $922 |
| Flecainide Acetate | 25 | $859 |
| Metoprolol Succinate | 38 | $785 |
| Sodium Chloride0.9 % Sodium Chloride | 17 | $416 |
| Amiodarone Hcl | 24 | $233 |
| Carvedilol | 14 | $168 |
| Minocycline Hcl | 32 | $163 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Ogden
- Saima HusainOgden$4K
- John RyanSalt Lake City$4.2M
- Brian WhisenantMurray$3.4M
- Jeffrey AndersonSalt Lake City$1.7M
- Divya Ratan VermaMurray$1.1M
- Robert FowlesSalt Lake City$611K
- Daniel HumistonFarmington$498K
- Kia AfsharMurray$442K
- Stephanie OlsenFarmington$406K
- Rami AlharethiMurray$403K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.